
### [MONDO:0015126](http://purl.obolibrary.org/obo/MONDO_0015126)
**Label:** polyendocrinopathy

**Subclasses:** [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0017169](http://purl.obolibrary.org/obo/MONDO_0017169) (multiple endocrine neoplasia), [MONDO:0015079](http://purl.obolibrary.org/obo/MONDO_0015079) (multiple polyglandular tumor), [MONDO:0017278](http://purl.obolibrary.org/obo/MONDO_0017278) (autoimmune polyendocrinopathy), [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), 

**Corr. equiv. classes:** [Orphanet:276161](http://www.orpha.net/ORDO/Orphanet_276161), [Orphanet:280651](http://www.orpha.net/ORDO/Orphanet_280651), [Orphanet:100094](http://www.orpha.net/ORDO/Orphanet_100094), [Orphanet:282196](http://www.orpha.net/ORDO/Orphanet_282196), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), 

**Class expressions from DL-Learner:**

- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) 66.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland) 66.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 66.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 66.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 66.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0007400](http://purl.obolibrary.org/obo/HP_0007400) (Irregular hyperpigmentation) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0007400](http://purl.obolibrary.org/obo/HP_0007400) (Irregular hyperpigmentation) 66.67%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 66.67%
- [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) 66.67%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 66.67%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) 66.67%


